Skip to content
777 Sourcing.

Capability

non-human primate studies

Suppliers
1
States & provinces
1
Countries
1

1 non-human primate studies supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

DIASTOL THERAPEUTICS, LLC

MINNEAPOLIS, MN

Diastol Therapeutics is an emerging biotechnology company developing a treatment for Heart Failure with Preserved Ejection Fraction (HFpEF) as its lead program. Founded in 2018, it is located in Chicago, IL/Minneapolis, MN, and aims to build a cardiovascular-focused company treating leading causes of death and morbidity. Its lead drug candidate is a first-in-class compound with a validated target, with ongoing non-human primate studies and IND filing planned within 18 months of financing.

clinical trialsCMC and tox studiesdrug developmentPD assays

Compiled from public sources

Related capabilities

Other processes offered by the shops that list non-human primate studies.

Browse all capabilities